How should I evaluate a pediatric patient (child or adolescent) presenting with excess terminal hair growth (hirsutism)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup of Hirsutism in Pediatric Patients

In a pediatric patient presenting with hirsutism, first confirm true terminal hair growth in androgen-dependent areas, then immediately assess for signs of virilization or rapid progression that would indicate an androgen-secreting tumor requiring urgent imaging, followed by targeted hormonal evaluation based on pubertal status and associated clinical features.

Initial Clinical Assessment

Confirm True Hirsutism vs. Hypertrichosis

  • Hirsutism refers specifically to excessive terminal (coarse) hair growth in androgen-dependent areas (upper lip, chin, chest, abdomen, back, inner thighs) in a male-like pattern 1, 2
  • Distinguish from hypertrichosis, which is generalized excessive hair growth not limited to androgen-dependent areas 3
  • Use the modified Ferriman-Gallwey (mFG) scoring system: scores ≥4-6 indicate hirsutism, though ethnic variation exists 3, 2

Red-Flag Features Requiring Urgent Evaluation

Immediately assess for virilization or tumor indicators:

  • Virilization signs: clitoromegaly, deepening voice, increased muscle mass, male-pattern baldness, breast atrophy 4, 5
  • Rapid onset (weeks to months) or severe progression suggests androgen-secreting tumor 5, 3
  • Very elevated testosterone (total testosterone >200 ng/dL) strongly suggests tumor 5
  • If any of these are present, proceed directly to pelvic ultrasound and adrenal imaging before extensive hormonal workup 5

Pubertal Status and Age-Specific Considerations

Prepubertal children (Tanner stage 1):

  • Hirsutism with early body odor, axillary/pubic hair, accelerated growth, advanced bone age, or genital maturation indicates premature adrenarche or virilizing disorder 4
  • Obtain growth charts and hand radiograph for bone age as initial screening tools 4
  • Consider Cushing syndrome if accompanied by weight gain with growth deceleration, buffalo hump, moon facies, or wide violaceous striae 4, 5

Postpubertal adolescents:

  • Assess for menstrual irregularities: oligomenorrhea (<9 cycles/year), amenorrhea (>6 months without menses), or polymenorrhea 5, 6
  • Look for PCOS features: acne, androgenic alopecia, acanthosis nigricans (insulin resistance marker), truncal obesity (waist-hip ratio >0.9) 4, 5, 6
  • Evaluate for infertility concerns if sexually active 5

Laboratory Evaluation Algorithm

First-Tier Testing (All Patients with Confirmed Hirsutism)

Morning (08:00-09:00h) fasting blood draw:

  • Total testosterone (or free/bioavailable testosterone if total is normal but clinical suspicion high) 4, 5, 3
  • DHEA-S (dehydroepiandrosterone sulfate) to assess adrenal androgen production 4, 5
  • 17-hydroxyprogesterone (early morning, follicular phase if menstruating) to screen for non-classic congenital adrenal hyperplasia 4, 5, 6
  • Prolactin (hyperprolactinemia occurs in 65% of pediatric GH excess cases and can cause hirsutism) 4, 7
  • TSH (thyroid dysfunction is part of PCOS differential) 4, 5

Interpretation and Second-Tier Testing

If total testosterone >200 ng/dL:

  • Urgent pelvic ultrasound to evaluate for ovarian tumor 5
  • Adrenal CT or MRI to evaluate for adrenal tumor 5

If 17-hydroxyprogesterone elevated:

  • Perform ACTH stimulation test to confirm non-classic congenital adrenal hyperplasia (21-hydroxylase deficiency) 4, 5, 6

If oligomenorrhea/amenorrhea present with moderate hirsutism:

  • LH and FSH (LH:FSH ratio >2:1 suggests PCOS) 4, 5
  • Fasting glucose and insulin or oral glucose tolerance test to assess insulin resistance 5, 6
  • Lipid panel to screen for metabolic syndrome 6
  • Pelvic ultrasound to identify polycystic ovarian morphology (>10 peripheral cysts 2-8mm diameter with thickened stroma) 5

If Cushing syndrome suspected (weight gain with growth deceleration, striae, moon facies):

  • 24-hour urinary free cortisol (3 consecutive collections; >193 nmol/24h or >70 μg/m² abnormal) 4
  • Late-night salivary cortisol (95% sensitivity, 100% specificity) 4
  • Low-dose dexamethasone suppression test (0.5mg every 6 hours for 48h; failure to suppress cortisol <50 nmol/L indicates Cushing syndrome) 4
  • If hypercortisolism confirmed, measure 09:00h plasma ACTH to distinguish ACTH-dependent from ACTH-independent causes 4

If GH excess suspected (excessive height >2 SDS, accelerated growth velocity, acromegalic features):

  • IGF-1 (age-, sex-, and Tanner stage-adjusted; elevated in 100% of GH excess) 4, 7
  • Oral glucose tolerance test with GH measurements (failure to suppress GH <1 μg/L suggests GH excess, though 30% of tall children fail to suppress normally) 4, 7
  • Pituitary MRI with contrast if biochemical testing positive 4, 7

Diagnostic Criteria for Common Causes

Polycystic Ovary Syndrome (PCOS)

Accounts for 70-80% of hirsutism cases 5, 1

In adolescents, diagnosis requires both of the following 4, 5:

  • Hyperandrogenism (clinical hirsutism/acne OR biochemical elevation of androgens)
  • Persistent oligomenorrhea (irregular cycles >2 years post-menarche)

In adults, diagnosis requires any 2 of 3 Rotterdam criteria 4, 5:

  • Hyperandrogenism (clinical or biochemical)
  • Ovulatory dysfunction (oligo- or anovulation)
  • Polycystic ovaries on ultrasound

Idiopathic Hirsutism

  • Accounts for 5-15% of hirsutism cases 1, 2
  • Normal ovulatory cycles (regular menses every 21-35 days) 1
  • Normal androgen levels (testosterone, DHEA-S, 17-hydroxyprogesterone all within reference range) 1, 2
  • Diagnosis of exclusion after ruling out other causes 2

Non-Classic Congenital Adrenal Hyperplasia

  • Accounts for 1-10% of hirsutism (varies by ethnicity) 2
  • Elevated basal 17-hydroxyprogesterone (typically >200 ng/dL) 5, 6
  • Confirmed by exaggerated 17-hydroxyprogesterone response to ACTH stimulation (>1000 ng/dL at 60 minutes) 4

When to Omit Extensive Hormonal Testing

Routine endocrinologic evaluation is NOT recommended for 4:

  • Mild hirsutism (mFG score <8) without other signs of hyperandrogenism
  • Isolated acne without hirsutism, menstrual irregularity, or virilization
  • Patients with clear exogenous androgen exposure (anabolic steroids, certain antiepileptics)

Critical Pitfalls to Avoid

  • Do not dismiss prepubertal hirsutism as "early puberty" without evaluating for premature adrenarche, virilizing tumors, or Cushing syndrome 4
  • Do not delay imaging in patients with rapid-onset hirsutism, virilization, or very elevated testosterone (>200 ng/dL), as these indicate possible malignancy 5, 3
  • Do not diagnose PCOS in early adolescence (<2 years post-menarche) based solely on irregular cycles, as menstrual irregularity is physiologic during this period 4, 5
  • Do not overlook Cushing syndrome in children with hirsutism plus unexplained weight gain and growth deceleration—this combination has high sensitivity and specificity 4
  • Do not use overnight dexamethasone suppression test alone in pediatrics (only 11-75% sensitivity); use 24-hour urinary free cortisol or late-night salivary cortisol instead 4
  • Do not forget genetic evaluation in prepubertal patients or those with family history of pituitary adenomas, as nearly 50% of pediatric pituitary tumors have identifiable genetic causes 4, 7

References

Research

The evaluation and management of hirsutism.

Obstetrics and gynecology, 2003

Research

Approach to the Patient: Hirsutism.

The Journal of clinical endocrinology and metabolism, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Primary Causes and Diagnosis of Hirsutism in Young Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evaluation and Management of Hyperandrogenism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Timing of GH Excess Determines Gigantism vs. Acromegaly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.